N-3 polyunsaturated fatty acids in psychiatric diseases: mechanisms and clinical data
Language English Country Sweden Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
23391975
PII: NEL331112R01
Knihovny.cz E-resources
- MeSH
- Mental Disorders immunology metabolism MeSH
- Humans MeSH
- Brain immunology metabolism MeSH
- Neuroimmunomodulation physiology MeSH
- Fatty Acids, Omega-3 metabolism MeSH
- Oxidative Stress physiology MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Fatty Acids, Omega-3 MeSH
The lipids constitute majority of dry weight of mature human brain. From lipids, 35% is comprised of PUFA with long chain (LC-PUFA), especially docosahexaenoic acid (DHA) of n-3 family and arachidonic acid (AA) of n-6 family. Humans are dependent on dietary intake of both AA and DHA. Interestingly, the dietary n-6/n-3 ratio increased considerably during last century. LC-PUFAs play numerous roles in the brain, including structural (forming the physico-chemical properties in the lipid bilayer of cellular membranes) and signaling ones. Moreover, they influence neurogenesis and neurotransmission within the nervous tissue. The metabolites of PUFA modulate immune and inflammatory processes in the brain, oxidative stress as well as its consequences. Of high importance is also their connection with several metabolic factors involved in the proper function of the brain and/or were discovered to play a role in the pathogenesis of neuropsychiatric diseases - melatonin, homocysteine, leptin, and adiponectin. This review gives short view of the metabolism and possible mechanisms of PUFA n-3 action in the brain, and their role in the pathogenesis of psychiatric diseases.